CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on AstraZeneca Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC ...
French biotech Abivax has been the subject of intense takeover speculation for months. But a spokesperson denied a report by ...
Three new cancer drugs could help AstraZenecaAZN make a dent in its lofty ambition to become an $80 billion company by 2030, an executive told Investor's Business Daily. On Sunday and Monday, ...
(Reuters) -Algen Biotechnologies said on Monday it had agreed to grant AstraZeneca a license to develop therapies the U.S.-based biotech discover using its AI-driven gene-editing platform, in a deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results